Development Level

Tbio 26 | 10,625
Tchem 15 | 1,890
Tclin 9 | 602
Tdark 2 | 7,003

IMPC Term

abnormal behavior 2 | 226
preweaning lethality, complete... 2 | 633
abnormal lens morphology 1 | 73
abnormal tooth morphology 1 | 24
absent teeth 1 | 4
cataract 1 | 26
decreased T cell number 1 | 31
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased circulating HDL chol... 1 | 77
decreased circulating choleste... 1 | 85
decreased effector memory CD8-... 1 | 24
decreased exploration in new e... 1 | 9
decreased grip strength 1 | 123
decreased lean body mass 1 | 195
decreased mean corpuscular hem... 1 | 34
decreased mean corpuscular vol... 1 | 50
decreased neutrophil cell numb... 1 | 37
decreased total body fat amoun... 1 | 186
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
hypoactivity 1 | 89
increased CD4-positive, alpha ... 1 | 15
increased bone mineral content 1 | 92
increased circulating alkaline... 1 | 119
increased circulating chloride... 1 | 43
increased circulating magnesiu... 1 | 10
increased circulating phosphat... 1 | 24
increased circulating sodium l... 1 | 71
increased erythrocyte cell num... 1 | 26
increased exploration in new e... 1 | 56
increased lean body mass 1 | 107
increased leukocyte cell numbe... 1 | 37
increased red blood cell distr... 1 | 21
tremors 1 | 34

Disease

psoriasis 28 | 6,685
osteosarcoma 26 | 7,933
Cancer 25 | 2,346
ovarian cancer 23 | 8,484
glioblastoma 19 | 5,572
lung cancer 19 | 4,466
medulloblastoma, large-cell 17 | 6,234
cutaneous lupus erythematosus 16 | 1,056
interstitial cystitis 16 | 2,299
lung carcinoma 16 | 2,844
diabetes mellitus 15 | 1,663
malignant mesothelioma 15 | 3,162
tuberculosis 15 | 1,557
pilocytic astrocytoma 14 | 3,086
ulcerative colitis 14 | 2,087
Breast cancer 13 | 3,094
Multiple Sclerosis 13 | 498
invasive ductal carcinoma 13 | 2,950
atypical teratoid / rhabdoid tumor 12 | 4,369
lung adenocarcinoma 12 | 2,713
Alzheimer's disease 11 | 644
Dementia 11 | 129
Hypersensitivity reaction type II disease 11 | 235
Obesity 11 | 616
Schizophrenia 11 | 501
pituitary cancer 11 | 1,972
subependymal giant cell astrocytoma 11 | 2,287
Asthma 10 | 349
Toxic encephalopathy 10 | 131
active Crohn's disease 10 | 918
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,956
Human immunodeficiency virus infectious disease 9 | 92
Kidney disease 9 | 396
Parkinson's disease 9 | 364
Rheumatoid Arthritis 9 | 1,160
cystic fibrosis 9 | 1,665
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,289
oligodendroglioma 9 | 2,849
pancreatic cancer 9 | 2,300
primitive neuroectodermal tumor 9 | 3,031
sarcoidosis 9 | 358
Anemia 8 | 252
Autistic Disorder 8 | 320
Bipolar Disorder 8 | 266
astrocytic glioma 8 | 2,241
astrocytoma 8 | 1,493
ependymoma 8 | 2,514
juvenile dermatomyositis 8 | 1,189
non-small cell lung cancer 8 | 2,798
pediatric high grade glioma 8 | 2,712
Acquired immunodeficiency syndrome 7 | 164
Atherosclerosis 7 | 275
Carcinoma 7 | 2,147
Diarrhea 7 | 155
Influenza 7 | 142
Liver disease 7 | 219
Malaria 7 | 140
Mammary Neoplasms 7 | 410
adult high grade glioma 7 | 2,148
breast carcinoma 7 | 1,614
colon cancer 7 | 1,475
dermatomyositis 7 | 933
group 4 medulloblastoma 7 | 1,875
primary Sjogren syndrome 7 | 789
Allergic hypersensitivity disease 6 | 123
Arthritis 6 | 248
Cerebrovascular disease 6 | 231
Cocaine-Related Disorders 6 | 88
Dengue disease 6 | 19
Encephalitis 6 | 54
Hepatitis C 6 | 90
Inflammatory bowel disease 6 | 142
Lung disease 6 | 132
Multiple myeloma 6 | 1,327
Nerve Degeneration 6 | 73
Polycystic Ovary Syndrome 6 | 332
esophageal adenocarcinoma 6 | 737
non primary Sjogren syndrome sicca 6 | 840
sonic hedgehog group medulloblastoma 6 | 1,482
Amphetamine-Related Disorders 5 | 74
Attention deficit hyperactivity disorder 5 | 156
Brain disease 5 | 83
Down syndrome 5 | 548
HIV Infections 5 | 100
Hepatitis B 5 | 103
Hypertension 5 | 287
Irritable bowel syndrome 5 | 59
Lung Neoplasms 5 | 171
Neuropathy 5 | 210
Parkinson Disease 5 | 102
Prostatic Neoplasms 5 | 471
Tetanus 5 | 66
Waldenstrons macroglobulinemia 5 | 765
ductal carcinoma in situ 5 | 1,745
head and neck cancer and chronic obstructive pulmonary disease 5 | 237
nasopharyngeal carcinoma 5 | 1,056
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,795
periodontitis 5 | 269
primary pancreatic ductal adenocarcinoma 5 | 1,271

Tissue

Blood and immune system 51 | 17,995
Digestive Tract 51 | 18,473
Endocrine System 51 | 18,512
Female tissues 51 | 18,647
Nervous System 51 | 18,561
Cardiovascular System 50 | 17,958
Liver and Pancreas 50 | 18,136
Male tissues 50 | 17,969
Skin and soft tissues 50 | 18,115
Urinary Tract 50 | 18,444
Respiratory system 48 | 17,484

Target Family

Non-IDG 34 | 11,971
Enzyme 5 | 4,146
GPCR 4 | 406
Kinase 4 | 634
Transporter 3 | 473
Nuclear Receptor 1 | 48
Transcription Factor 1 | 1,400

Grant Application

5P51RR000168-49 52 | 52
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Semaphorin-3E SEMA3E Tbio Non-IDG -1.51645 40.3 201
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
Peptide YY PYY Tbio Non-IDG -3.05547 1229.8 256
Tryptophan--tRNA ligase, cytoplasmic WARS Tbio Enzyme -2.98787 974.3 154
Tyrosine-protein phosphatase non-receptor type 11 PTPN11 Tchem Enzyme -3.06784 1308.8 971
Syncytin-1 ERVW-1 Tbio Non-IDG -3.60744 3712.1 143
Bone marrow stromal antigen 2 BST2 Tbio Non-IDG -2.50565 392.8 343